Concepedia

Abbas M. Walji

AM

Statistics

Publications

22

Citations

2.2K

H-Index

18

Active since

2002

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

University at Buffalo, State University of New York

Princeton University

IRBM Science Park

United States Military Academy

Abbas M. Walji is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in engineering, natural sciences, and chemistry.

ORCID

Top concepts

Publications per year

2002–2023

22

Publications

22

Enantioselective Organo-Cascade Catalysis

Yong Huang, Abbas M. Walji, Catharine H. Larsen et al. · Journal of the American Chemical Society · 2005 · 730 citations

, , +14

Cycle‐Specific Organocascade Catalysis: Application to Olefin Hydroamination, Hydro‐oxidation, and Amino‐oxidation, and to Natural Product Synthesis

Bryon Simmons, Abbas M. Walji, David W. C. MacMillan · Angewandte Chemie International Edition · 2009 · 275 citations · Full text

, , +14

A Series of Novel, Highly Potent, and Orally Bioavailable Next-Generation Tricyclic Peptide PCSK9 Inhibitors

Thomas J. Tucker, Mark W. Embrey, Candice Alleyne et al. · Journal of Medicinal Chemistry · 2021 · 140 citations · Full text

Orally Bioavailable Macrocyclic Peptide That Inhibits Binding of PCSK9 to the Low Density Lipoprotein Receptor

Douglas G. Johns, Louis‐Charles Campeau, Puja Banka et al. · Circulation · 2023 · 118 citations · Full text

Direct and enantioselective α-allylation of ketones via singly occupied molecular orbital (SOMO) catalysis

Anthony Mastracchio, Alexander A. Warkentin, Abbas M. Walji et al. · Proceedings of the National Academy of Sciences · 2010 · 115 citations · Full text

, , +13

1–5 of 22